[1]胡容,王丹,楼丹丹,等.胰岛素对阿尔茨海默病细胞模型淀粉样前体蛋白代谢的影响[J].第三军医大学学报,2020,42(12):1201-1208.
 HU Rong,WANG Dan,LOU Dandan,et al.Insulin promotes amyloid precursor protein metabolism in an Alzheimer’s disease cell model [J].J Third Mil Med Univ,2020,42(12):1201-1208.
点击复制

胰岛素对阿尔茨海默病细胞模型淀粉样前体蛋白代谢的影响(/HTML )
分享到:

《第三军医大学学报》[ISSN:1000-5404/CN:51-1095/R]

卷:
42卷
期数:
2020年第12期
页码:
1201-1208
栏目:
神经科学
出版日期:
2020-06-30

文章信息/Info

Title:
Insulin promotes amyloid precursor protein metabolism in an Alzheimer’s disease cell model
 
作者:
胡容王丹 楼丹丹李廷玉周卫辉宋伟宏
重庆医科大学附属儿童医院儿科医学研究所,儿童发育疾病研究教育部重点实验室,儿童发育重大疾病国家国际科技合作基地,儿科学重庆市重点实验室
Author(s):
HU Rong WANG Dan LOU Dandan LI Tingyu ZHOU Weihui SONG Weihong

Institute of Pediatrics,  Key Laboratory of Child Development and Disorders of Ministry of Education, Chongqing International Science and Technology Cooperation Base for Child Development and Critical Disorders, Chongqing Key Laboratory of Pediatrics, Children's Hospital of Chongqing Medical University, Chongqing, 400014, China

关键词:
阿尔茨海默病胰岛素淀粉样前体蛋白&beta淀粉样蛋白AKT/GSK3&beta
Keywords:
Alzheimer&rsquos disease insulin amyloid precursor protein &beta-amyloid AKT/GSK3&beta  
分类号:
R341;R745.7;R977.15
文献标志码:
A
摘要:

目的探索胰岛素通过影响淀粉样前体蛋白(amyloid precursor protein,APP)代谢对阿尔茨海默病(Alzheimer’s disease,AD)细胞模型的作用。方法采用不同浓度的胰岛素处理人神经母细胞瘤细胞株SH-SY5Y和非神经源性细胞株HEK293、2EB2,CCK-8法检测胰岛素对细胞活性的影响;Western blot检测2EB2细胞和SH-SY5Y细胞经不同浓度胰岛素处理后APP、CTF、BACE1、ADAM10和PS1的表达,ELISA法检测Aβ40和Aβ42的水平;蛋白芯片筛选胰岛素介导的关键信号通路分子,Western blot检测上述细胞中胰岛素对信号通路AKT以及GSK3β蛋白磷酸化水平的影响。结果CCK-8检测结果显示,0~10 μmol/L胰岛素浓度未对实验细胞的活性产生影响(P>0.05)。Western blot结果显示,与未处理组相比,1.00、10.00 μmol/L胰岛素处理增加了APP、CTF的表达(P<0.05);在APP代谢关键酶中,BACE1表达显著增加(P<0.05)。ELISA结果显示1.00、10.00 μmol/L胰岛素干预后,Aβ42的水平显著增加(P<0.05)。同时,蛋白芯片发现GSK3β为胰岛素作用的潜在靶点。Western blot结果显示,磷酸化AKT和磷酸化GSK3β蛋白的表达均下调,但差异无统计学意义(P>0.05)。结论胰岛素对阿尔茨海默病致病性产物的产生有增强作用。

Abstract:

ObjectiveTo investigate how insulin affects the metabolism of amyloid precursor protein (APP) in a cell model of Alzheimer’s disease (AD). MethodsHuman neuroblastoma SH-SY5Y cells and the nonneural cell lines HEK293 and 2EB2 were treated with different concentrations of insulin for 48 h, and the changes in cell viability were evaluated with CCK-8 assay. The expression levels of APP, C-terminal fragment of APP (CTF), β-site APP cleaving enzyme 1 (BACE1), the α-secretase ADAM10 (a disintegrin and metalloproteinase 10) and γ-secretase presenilin 1 (PS1) in the cells were detected using Western blotting. ELISA was used to determine the cellular expression levels of Aβ40 and Aβ42. The key signaling pathways mediated by insulin were screened using a protein chip. The effect of insulin on protein phosphorylation levels of AKT and GSK3β pathways was examined by detecting p-AKT and p-GSK3β expression in the cells with Western blotting. ResultsTreatment with insulin below 10 μmol/L did not obviously affect the viability of the cells (P>0.05). Western blotting showed that treatment with 1.00 and 10.00 μmol/L insulin significantly increased the protein expression of APP and CTF (P<0.05) and also the expression of BACE1, a key enzyme for APP metabolism (P<0.05). The results of ELISA demonstrated that the expression level of Aβ42 increased significantly in the cells following treatment with 1.00 and 10.00 μmol/L insulin (P<0.05). The protein microarray data identified GSK3β as a potential target of insulin. Western blot analysis showed that the expression of p-AKT and p-GSK3β proteins was down-regulated following insulin treatment, but the differences were not statistically significant (P>0.05). ConclusionInsulin promotes the metabolism of APP into CTF and Aβ42, which play certain rolesin pathogenesis of AD.

参考文献/References:

[1]DARTIGUES J F. Alzheimer’s disease: a global challenge for the 21st century[J]. Lancet Neurol, 2009, 8(12): 1082-1083. DOI:10.1016/S1474-4422(09)70298-4.

[2]ZHANG X J, SONG W H. The role of APP and BACE1 trafficking in APP processing and amyloid-β generation[J]. Alzheimers Res Ther, 2013, 5(5): 46. DOI:10.1186/alzrt211.

[3]SUN X L, BROMLEY-BRITS K, SONG W H. Regulation of β-site APP-cleaving enzyme 1 gene expression and its role in Alzheimer’s disease[J]. J Neurochem, 2012, 120(Suppl 1): 62-70. DOI: 10.1111/j.1471-4159.2011.07515.x.

[4]SINHA S, ANDERSON J P, BARBOUR R, et al. Purification and cloning of amyloid precursor protein beta-secretase from human brain[J]. Nature, 1999, 402(6761): 537-540. DOI: 10.1038/990114.

[5]GASPARINI L, NETZER W J, GREENGARD P, et al. Does insulin dysfunction play a role in Alzheimer’s disease?[J]. Trends Pharmacol Sci, 2002, 23(6): 288-293. DOI: 10.1016/s0165-6147(02)02037-0.

[6]GASPARINI L, XU H X. Potential roles of insulin and IGF-1 in Alzheimer’s disease[J]. Trends Neurosci, 2003, 26(8): 404-406. DOI: 10.1016/S0166-2236(03)00163-2.

[7]STEEN E, TERRY B M, RIVERA E J, et al. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer’s disease: is This type 3 diabetes?[J]. J Alzheimers Dis, 2005, 7(1): 63-80. DOI: 10.3233/jad-2005-7107.

[8]LEBOUVIER T, SCALES T M E, HANGER D P, et al. The microtubule-associated protein tau is phosphorylated by Syk[J]. Biochim Et Biophys Acta BBA - Mol Cell Res, 2008, 1783(2): 188-192. DOI: 10.1016/j.bbamcr.2007.11.005.

[9]IWATSUBO T. Amyloid beta protein in plasma as a diagnostic marker for Alzheimer’s disease[J]. Neurobiol Aging, 1998, 19(2): 161-163. DOI: 10.1016/s0197-4580(98)00015-3.

[10]LANNERT H, HOYER S. Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats[J]. Behav Neurosci, 1998, 112(5): 1199-1208. DOI: 10.1037//0735-7044.112.5.1199.

[11]GASPARINI L, GOURAS G K, WANG R, et al. Stimulation of beta-amyloid precursor protein trafficking by insulin reduces intraneuronal beta-amyloid and requires mitogen-activated protein kinase signaling[J]. J Neurosci, 2001, 21(8): 2561-2570.

[12]BIEDLER J L, ROFFLER-TARLOV S, SCHACHNER M, et al. Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones[J]. Cancer Res, 1978, 38(11 Pt 1): 3751-3757.

[13]KOVALEVICH J, LANGFORD D. Considerations for the use of SH-SY5Y neuroblastoma cells in neurobiology[J]. Methods Mol Biol, 2013, 1078: 9-21. DOI: 10.1007/978-1-62703-640-5_2.

[14]QIU W Q, WALSH D M, YE Z, et al. Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation[J]. J Biol Chem, 1998, 273(49): 32730-32738. DOI: 10.1074/jbc.273.49.32730.

[15]RAJASEKAR N, NATH C, HANIF K, et al. Intranasal insulin administration ameliorates streptozotocin (ICV)-induced insulin receptor dysfunction, neuroinflammation, amyloidogenesis, and memory impairment in rats[J]. Mol Neurobiol, 2017, 54(8): 6507-6522. DOI: 10.1007/s12035-016-0169-8.

[16]MIKLOSSY J, QING H, RADENOVIC A, et al. Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes[J]. Neurobiol Aging, 2010, 31(9): 1503-1515. DOI: 10.1016/j.neurobiolaging.2008.08.019.

[17]SALTIEL A R, KAHN C R. Insulin signalling and the regulation of glucose and lipid metabolism[J]. Nature, 2001, 414(6865):  799-806. DOI: 10.1038/414799a.

[18]ROHER A E, ESH C L, KOKJOHN T A, et al. Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer’s disease[J]. Alzheimers Dement, 2009, 5(1): 18-29. DOI: 10.1016/j.jalz.2008.10.004.

[19]GASPARINI L, GOURAS G K, WANG R, et al. Stimulation of beta-amyloid precursor protein trafficking by insulin reduces intraneuronal beta-amyloid and requires mitogen-activated protein kinase signaling[J]. J Neurosci, 2001, 21(8):  2561-2570.

[20]TAKEDA S, SATO N, UCHIO-YAMADA K, et al. Elevation of plasma beta-amyloid level by glucose loading in Alzheimer mouse models[J]. Biochem Biophys Res Commun, 2009, 385(2):  193-197. DOI: 10.1016/j.bbrc.2009.05.037.

[21]GASPARINI L, NETZER W J, GREENGARD P, et al. Does insulin dysfunction play a role in Alzheimer’s disease?[J]. Trends Pharmacol Sci, 2002, 23(6):  288-293. DOI: 10.1016/s0165-6147(02)02037-0.

[22]GASPARINI L, XU H X. Potential roles of insulin and IGF-1 in Alzheimer’s disease[J]. Trends Neurosci, 2003, 26(8):  404-406. DOI: 10.1016/S0166-2236(03)00163-2.

[23]QIU W Q, WALSH D M, YE Z, et al. Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation[J]. J Biol Chem, 1998, 273(49):  32730-32738. DOI: 10.1074/jbc.273.49.32730.

相似文献/References:

[1]郑宏庭,邓华聪,兰丽珍,等.稳定表达人胰岛素原突变基因的HepG2细胞构建及其胰岛素分泌[J].第三军医大学学报,2007,29(24):2361.
 ZHENG Hong-ting,DENG Hua-cong,LAN Li-zhen,et al.Construction and insulin secretion of HepG2 cell stably expressing mutated human proinsulin gene[J].J Third Mil Med Univ,2007,29(12):2361.
[2]王旭开,王燕,杨成明,等.胰岛素对大鼠血管平滑肌细胞增殖及胶原蛋白合成的影响[J].第三军医大学学报,2006,28(24):2416.
[3]石伟彬,杨成明,刘光耀,等.下丘脑胰岛素及其受体在高血压大鼠的变化及与血压的关系[J].第三军医大学学报,2006,28(24):2448.
[4]汪娟,许莉,张兴禹.胰岛素治疗新诊断的2型糖尿病的疗效观察[J].第三军医大学学报,2005,27(15):1621.
[5]杨黎,甘华,杜晓刚,等.高糖及胰岛素对肾小管上皮细胞间隙连接蛋白43表达的影响[J].第三军医大学学报,2009,31(17):1672.
 YANG Li,GAN Hua,DU Xiao-gang,et al.High glucose and insulin enhance expression of connexin43 in cultured human renal tubular epithelial cells[J].J Third Mil Med Univ,2009,31(12):1672.
[6]周恒宇,邓华聪,郑宏庭,等.磷脂酶Cβ1过表达对葡萄糖刺激胰岛素分泌的影响[J].第三军医大学学报,2009,31(15):1471.
 ZHOU Heng-yu,DENG Hua-cong,ZHENG Hong-ting,et al.Overexpression of phospholipase cβ1 improves glucose-stimulated insulin secretion in INS cells[J].J Third Mil Med Univ,2009,31(12):1471.
[7]张阳,卢永辉,缪洪明,等.肿瘤坏死因子-α拮抗瘦素抑制胰岛素合成及分泌作用的实验观察[J].第三军医大学学报,2011,33(06):558.
 Zhang Yang,Lu Yonghui,Miao Hongming,et al.Antagonistic effect of TNF-α on leptin-mediated inhibition of insulin synthesis and secretion in INS-1E cells and rat pancreatic islets[J].J Third Mil Med Univ,2011,33(12):558.
[8]张晓,魏平,谭明红,等.2型糖尿病患者糖化血红蛋白水平控制及胰岛素使用对认知功能的影响[J].第三军医大学学报,2014,36(10):1078.
 Zhang Xiao,Wei Ping,Tan Minghong,et al.Effect of controlling glycated hemoglobin A1c and applying of insulin on cognitive function in type 2 diabetes patients[J].J Third Mil Med Univ,2014,36(12):1078.
[9]毛旭虎,许霖水.胰岛素受体酪氨酸蛋白激酶在重度烫伤大鼠胰岛素抵抗中作用的研究[J].第三军医大学学报,1996,18(01):0.[doi:10.16016/j.1000-5404.1996.01.001 ]
 Mao Xuhu,Xu Linshui.[J].J Third Mil Med Univ,1996,18(12):0.[doi:10.16016/j.1000-5404.1996.01.001 ]
[10]姚忠祥,李巍,李成仁,等.体外培养神经干细胞分化为类胰岛样组织的研究[J].第三军医大学学报,2003,25(01):0.[doi:10.16016/j.1000-5404.2003.01.011 ]
 YAO Zhong xiang,LI Wei,LI Cheng ren,et al.[J].J Third Mil Med Univ,2003,25(12):0.[doi:10.16016/j.1000-5404.2003.01.011 ]

更新日期/Last Update: 2020-06-19